Osaghae Ikponmwosa, Darkoh Charles, Chido-Amajuoyi Onyema Greg, Chan Wenyaw, Padgett Wermuth Paige, Pande Mala, Cunningham Sonia A, Shete Sanjay
Department of Epidemiology, Human Genetics and Environmental Sciences, The University of Texas Health Science Center at Houston (UTHealth) School of Public Health, Houston, TX 77030, USA.
Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Vaccines (Basel). 2023 Jan 30;11(2):300. doi: 10.3390/vaccines11020300.
HPV vaccine hesitancy is a key contributor to the sub-optimal HPV vaccination uptake in the United States. We aimed to determine the association between healthcare providers' self-efficacy in HPV vaccination hesitancy counseling and HPV vaccination acceptance after initial and follow-up counseling sessions.
Population-based cross-sectional study of healthcare providers (HCPs) practicing in Texas. Logistic regression analyses were used to determine the odds of HPV vaccination acceptance by vaccine-hesitant patients. Additionally, generalized estimating equations were used to compare HPV vaccination acceptance by hesitant patients after follow-up versus initial counseling sessions.
1283 HCPs completed the survey with a mean (SD) age of 47.1 (11.3) years. HCPs who believed that they were very/completely confident in counseling HPV-vaccine-hesitant parents had higher odds of observing HPV vaccination acceptance very often/always after an initial counseling session (adjusted odds ratio (AOR): 3.50; 95% CI: 2.25-5.44) and after follow-up counseling sessions (AOR: 2.58; 95% CI: 1.66-4.00) compared to HCPs that perceived they were not at all/somewhat/moderately confident. The odds of HPV vaccination being accepted very often/always by vaccine-hesitant parents was 61% (AOR: 1.61; 95% CI: 1.32-1.95) higher after follow-up counseling sessions compared to an initial counseling session. The results were similar for the counseling of HPV-vaccine-hesitant adult patients.
The confidence level of HCPs in counseling hesitant parents and adult patients impacts HPV vaccination acceptance. Importantly, acceptance was higher after follow-up counseling sessions than initial counseling sessions. HCPs should receive training in HPV vaccination counseling to enhance their confidence in counseling hesitant patients and should utilize every visit to counsel hesitant patients.
人乳头瘤病毒(HPV)疫苗接种犹豫是美国HPV疫苗接种率未达最优水平的一个关键因素。我们旨在确定医疗服务提供者在HPV疫苗接种犹豫咨询方面的自我效能与初次及后续咨询 sessions 后HPV疫苗接种接受情况之间的关联。
对在德克萨斯州执业的医疗服务提供者(HCPs)进行基于人群的横断面研究。逻辑回归分析用于确定对疫苗犹豫的患者接受HPV疫苗接种的几率。此外,广义估计方程用于比较后续咨询 sessions 与初次咨询 sessions 后犹豫患者的HPV疫苗接种接受情况。
1283名HCPs完成了调查,平均(标准差)年龄为47.1(11.3)岁。与那些认为自己完全没有/有点/中等信心的HCPs相比,那些认为自己在为HPV疫苗犹豫的父母提供咨询方面非常/完全有信心的HCPs,在初次咨询 session 后(调整优势比(AOR):3.50;95%置信区间:2.25 - 5.44)和后续咨询 session 后(AOR:2.58;95%置信区间:1.66 - 4.00)观察到HPV疫苗接种接受情况非常频繁/总是如此的几率更高。与初次咨询 session 相比,后续咨询 session 后对疫苗犹豫的父母非常频繁/总是接受HPV疫苗接种的几率高61%(AOR:1.61;95%置信区间:1.32 - 1.95)。对HPV疫苗犹豫的成年患者的咨询结果相似。
HCPs在为犹豫的父母和成年患者提供咨询方面的信心水平会影响HPV疫苗接种接受情况。重要的是,后续咨询 session 后的接受率高于初次咨询 session。HCPs应接受HPV疫苗接种咨询培训,以增强他们为犹豫的患者提供咨询的信心,并应利用每次就诊机会为犹豫的患者提供咨询。